These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 31679829)

  • 1. The ATLANTIC study: Anti-Xa level assessment in trauma intensive care.
    Rakhra S; Martin EL; Fitzgerald M; Udy A
    Injury; 2020 Jan; 51(1):10-14. PubMed ID: 31679829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association Between Enoxaparin Dosage Adjusted by Anti-Factor Xa Trough Level and Clinically Evident Venous Thromboembolism After Trauma.
    Ko A; Harada MY; Barmparas G; Chung K; Mason R; Yim DA; Dhillon N; Margulies DR; Gewertz BL; Ley EJ
    JAMA Surg; 2016 Nov; 151(11):1006-1013. PubMed ID: 27383732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Weight- and Anti-Xa-Guided Enoxaparin Dosing Protocol for venous thromboembolism Prophylaxis in intensive care unit Trauma Patients.
    Bigos R; Solomon E; Dorfman JD; Ha M
    J Surg Res; 2021 Sep; 265():122-130. PubMed ID: 33930618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective Evaluation of Weight-Based Prophylactic Enoxaparin Dosing in Critically Ill Trauma Patients: Adequacy of AntiXa Levels Is Improved.
    Nunez JM; Becher RD; Rebo GJ; Farrah JP; Borgerding EM; Stirparo JJ; Lauer C; Kilgo P; Miller PR
    Am Surg; 2015 Jun; 81(6):605-9. PubMed ID: 26031274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Anti-Factor Xa-Guided Dosing of Enoxaparin With Venous Thromboembolism After Trauma.
    Karcutskie CA; Dharmaraja A; Patel J; Eidelson SA; Padiadpu AB; Martin AG; Lama G; Lineen EB; Namias N; Schulman CI; Proctor KG
    JAMA Surg; 2018 Feb; 153(2):144-149. PubMed ID: 29071333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trauma patients with lower extremity and pelvic fractures: Should anti-factor Xa trough level guide prophylactic enoxaparin dose?
    Dhillon NK; Smith EJT; Gillette E; Mason R; Barmparas G; Gewertz BL; Ley EJ
    Int J Surg; 2018 Mar; 51():128-132. PubMed ID: 29367044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Weight-Based Enoxaparin Achieves Adequate Anti-Xa Levels More Often in Trauma Patients: A Prospective Study.
    Stutsrim AE; Eady JM; Collum M; Rebo GJ; Rebo KA; Miller PR; Nunn AM
    Am Surg; 2021 Jan; 87(1):77-82. PubMed ID: 32915054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation of antifactor-Xa peak levels and venous thromboembolism after trauma.
    Karcutskie CA; Dharmaraja A; Patel J; Eidelson SA; Martin AG; Lineen EB; Namias N; Schulman CI; Proctor KG
    J Trauma Acute Care Surg; 2017 Dec; 83(6):1102-1107. PubMed ID: 29190255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Weight on Anti-Xa Attainment in High-Risk Trauma Patients on Enoxaparin Chemoprophylaxis.
    Farrar JE; Droege ME; Philpott CD; Mueller EW; Ernst NE; Makley AT; Deichstetter KM; Droege CA
    J Surg Res; 2021 Aug; 264():425-434. PubMed ID: 33848842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-Xa-guided enoxaparin thromboprophylaxis reduces rate of deep venous thromboembolism in high-risk trauma patients.
    Singer GA; Riggi G; Karcutskie CA; Vaghaiwalla TM; Lieberman HM; Ginzburg E; Namias N; Lineen EB
    J Trauma Acute Care Surg; 2016 Dec; 81(6):1101-1108. PubMed ID: 27488490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of a dalteparin prophylaxis protocol using anti-factor Xa concentrations on venous thromboembolism in high-risk trauma patients.
    Droege ME; Mueller EW; Besl KM; Lemmink JA; Kramer EA; Athota KP; Droege CA; Ernst NE; Keegan SP; Lutomski DM; Hanseman DJ; Robinson BR
    J Trauma Acute Care Surg; 2014 Feb; 76(2):450-6. PubMed ID: 24458050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose adjusting enoxaparin is necessary to achieve adequate venous thromboembolism prophylaxis in trauma patients.
    Costantini TW; Min E; Box K; Tran V; Winfield RD; Fortlage D; Doucet J; Bansal V; Coimbra R
    J Trauma Acute Care Surg; 2013 Jan; 74(1):128-33; discussion 134-5. PubMed ID: 23271087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Characteristics Associated With Higher Enoxaparin Dosing Requirements for Venous Thromboembolism Prophylaxis in Trauma Patients.
    Hashim YM; Dhillon NK; Veatch JM; Barmparas G; Ley EJ
    Am Surg; 2021 Jul; 87(7):1177-1181. PubMed ID: 33342267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low molecular weight heparin for venous thromboembolism prophylaxis in general Intensive Care Unit patients: an anti-factor Xa level-based approach.
    Zohar N; Ellis MH; Dichtwald S; Meyer A; Zohar E; Ifrach N
    Minerva Anestesiol; 2023 May; 89(5):425-433. PubMed ID: 36326777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Weight-based enoxaparin dosing for venous thromboembolism prophylaxis in the obese trauma patient.
    Bickford A; Majercik S; Bledsoe J; Smith K; Johnston R; Dickerson J; White T
    Am J Surg; 2013 Dec; 206(6):847-51, discussion 851-2. PubMed ID: 24070664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Standard prophylactic enoxaparin dosing leads to inadequate anti-Xa levels and increased deep venous thrombosis rates in critically ill trauma and surgical patients.
    Malinoski D; Jafari F; Ewing T; Ardary C; Conniff H; Baje M; Kong A; Lekawa ME; Dolich MO; Cinat ME; Barrios C; Hoyt DB
    J Trauma; 2010 Apr; 68(4):874-80. PubMed ID: 20386282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioactivity of enoxaparin in critically ill patients with normal renal function.
    Gouya G; Palkovits S; Kapiotis S; Madl C; Locker G; Stella A; Wolzt M; Heinz G
    Br J Clin Pharmacol; 2012 Nov; 74(5):806-14. PubMed ID: 23227470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inability to predict subprophylactic anti-factor Xa levels in trauma patients receiving early low-molecular-weight heparin.
    Imran JB; Madni TD; Clark AT; Rizk P; Huang E; Minshall CT; Taveras LR; Cunningham HB; Eastman AL; Koshy JP; Kacir CD; Cripps MW
    J Trauma Acute Care Surg; 2018 Nov; 85(5):867-872. PubMed ID: 29985229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Weight-Based Dosing for Low-Molecular-Weight Heparin (Enoxaparin) Administration to Achieve Optimal VTE Prophylaxis in Trauma Patients.
    Thind T; Heye T; Henson C; Reif R; Jensen HK; Kalkwarf KJ; Bhavaraju A; Robertson R; Jenkins A
    Am Surg; 2024 Jun; 90(6):1406-1411. PubMed ID: 38518208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternative dosing of prophylactic enoxaparin in the trauma patient: is more the answer?
    Kopelman TR; O'Neill PJ; Pieri PG; Salomone JP; Hall ST; Quan A; Wells JR; Pressman MS
    Am J Surg; 2013 Dec; 206(6):911-5; discussion 915-6. PubMed ID: 24296098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.